APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174002670126 December 2025122 pages

Choose your research edition.

Industry ResearchInfluenza Drugs and Vaccines Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Influenza Drugs and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza Drugs and Vaccines include CSL, Alvogen, AstraZeneca, BioCryst Pharmaceuticals, Bristol Myers Squibb, Celgene, Emergent Biosolutions, GlaxoSmithKline and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Influenza Drugs and Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza Drugs and Vaccines market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza Drugs and Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza Drugs and Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Influenza Drugs and Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza Drugs and Vaccines Market by Company

CSL

Alvogen

AstraZeneca

BioCryst Pharmaceuticals

Bristol Myers Squibb

Celgene

Emergent Biosolutions

GlaxoSmithKline

Hulan Bio

Protein Sciences Corporation

Seqirus

Serum Institute of India

Viatris

Beike Bio

Bayer

Pfizer

Jiangsu GDK

Sinovac

Eli Lilly

Roche

Novartis

Sanofi

Changchun Institute of Biological

Influenza Drugs and Vaccines Segment by Type

Influenza Drugs

Influenza Vaccines

Influenza Drugs and Vaccines Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Influenza Drugs and Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Influenza Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Influenza Drugs Table 2. Major Company of Influenza Vaccines Table 3. Global Influenza Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 5. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Influenza Drugs and Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Influenza Drugs and Vaccines Price by Type (2021-2026) & (US$/Kg) Table 9. Global Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 10. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Influenza Drugs and Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Influenza Drugs and Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Influenza Drugs and Vaccines Price by Type (2027-2032) & (US$/Kg) Table 14. North America Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 15. North America Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 17. Europe Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 21. Latin America Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Influenza Drugs and Vaccines Industry Trends Table 25. Influenza Drugs and Vaccines Industry Drivers Table 26. Influenza Drugs and Vaccines Industry Opportunities and Challenges Table 27. Influenza Drugs and Vaccines Industry Restraints Table 28. Global Influenza Drugs and Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Influenza Drugs and Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Influenza Drugs and Vaccines Sales by Company (2021-2026) & (Tons) Table 31. Global Influenza Drugs and Vaccines Sales Share by Company (2021-2026) Table 32. Global Influenza Drugs and Vaccines Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Influenza Drugs and Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Influenza Drugs and Vaccines Major Company Production Sites and Headquarters Table 35. Global Influenza Drugs and Vaccines Company, Product Type & Application Table 36. Global Influenza Drugs and Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Influenza Drugs and Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (Tons) Table 41. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Influenza Drugs and Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Influenza Drugs and Vaccines Sales by Region (2027-2032) & (Tons) Table 46. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Influenza Drugs and Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Influenza Drugs and Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Influenza Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 52. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Influenza Drugs and Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Influenza Drugs and Vaccines Price by Application (2021-2026) & (US$/Kg) Table 56. Global Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 57. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Influenza Drugs and Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Influenza Drugs and Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Influenza Drugs and Vaccines Price by Application (2027-2032) & (US$/Kg) Table 61. North America Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 62. North America Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 64. Europe Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 68. Latin America Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Company Information Table 72. CSL Business Overview Table 73. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. CSL Influenza Drugs and Vaccines Product Portfolio Table 75. CSL Recent Development Table 76. Alvogen Company Information Table 77. Alvogen Business Overview Table 78. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Alvogen Influenza Drugs and Vaccines Product Portfolio Table 80. Alvogen Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. AstraZeneca Influenza Drugs and Vaccines Product Portfolio Table 85. AstraZeneca Recent Development Table 86. BioCryst Pharmaceuticals Company Information Table 87. BioCryst Pharmaceuticals Business Overview Table 88. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio Table 90. BioCryst Pharmaceuticals Recent Development Table 91. Bristol Myers Squibb Company Information Table 92. Bristol Myers Squibb Business Overview Table 93. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio Table 95. Bristol Myers Squibb Recent Development Table 96. Celgene Company Information Table 97. Celgene Business Overview Table 98. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Celgene Influenza Drugs and Vaccines Product Portfolio Table 100. Celgene Recent Development Table 101. Emergent Biosolutions Company Information Table 102. Emergent Biosolutions Business Overview Table 103. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio Table 105. Emergent Biosolutions Recent Development Table 106. GlaxoSmithKline Company Information Table 107. GlaxoSmithKline Business Overview Table 108. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio Table 110. GlaxoSmithKline Recent Development Table 111. Hulan Bio Company Information Table 112. Hulan Bio Business Overview Table 113. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Hulan Bio Influenza Drugs and Vaccines Product Portfolio Table 115. Hulan Bio Recent Development Table 116. Protein Sciences Corporation Company Information Table 117. Protein Sciences Corporation Business Overview Table 118. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio Table 120. Protein Sciences Corporation Recent Development Table 121. Seqirus Company Information Table 122. Seqirus Business Overview Table 123. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Seqirus Influenza Drugs and Vaccines Product Portfolio Table 125. Seqirus Recent Development Table 126. Serum Institute of India Company Information Table 127. Serum Institute of India Business Overview Table 128. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Serum Institute of India Influenza Drugs and Vaccines Product Portfolio Table 130. Serum Institute of India Recent Development Table 131. Viatris Company Information Table 132. Viatris Business Overview Table 133. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. Viatris Influenza Drugs and Vaccines Product Portfolio Table 135. Viatris Recent Development Table 136. Beike Bio Company Information Table 137. Beike Bio Business Overview Table 138. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Beike Bio Influenza Drugs and Vaccines Product Portfolio Table 140. Beike Bio Recent Development Table 141. Bayer Company Information Table 142. Bayer Business Overview Table 143. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 144. Bayer Influenza Drugs and Vaccines Product Portfolio Table 145. Bayer Recent Development Table 146. Pfizer Company Information Table 147. Pfizer Business Overview Table 148. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 149. Pfizer Influenza Drugs and Vaccines Product Portfolio Table 150. Pfizer Recent Development Table 151. Jiangsu GDK Company Information Table 152. Jiangsu GDK Business Overview Table 153. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 154. Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio Table 155. Jiangsu GDK Recent Development Table 156. Sinovac Company Information Table 157. Sinovac Business Overview Table 158. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 159. Sinovac Influenza Drugs and Vaccines Product Portfolio Table 160. Sinovac Recent Development Table 161. Eli Lilly Company Information Table 162. Eli Lilly Business Overview Table 163. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 164. Eli Lilly Influenza Drugs and Vaccines Product Portfolio Table 165. Eli Lilly Recent Development Table 166. Roche Company Information Table 167. Roche Business Overview Table 168. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 169. Roche Influenza Drugs and Vaccines Product Portfolio Table 170. Roche Recent Development Table 171. Novartis Company Information Table 172. Novartis Business Overview Table 173. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 174. Novartis Influenza Drugs and Vaccines Product Portfolio Table 175. Novartis Recent Development Table 176. Sanofi Company Information Table 177. Sanofi Business Overview Table 178. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 179. Sanofi Influenza Drugs and Vaccines Product Portfolio Table 180. Sanofi Recent Development Table 181. Changchun Institute of Biological Company Information Table 182. Changchun Institute of Biological Business Overview Table 183. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 184. Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio Table 185. Changchun Institute of Biological Recent Development Table 186. North America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 187. North America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 188. North America Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 189. North America Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032) & (Tons) Table 190. North America Influenza Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 191. North America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. North America Influenza Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 193. North America Influenza Drugs and Vaccines Market Share by Country (2021-2026) Table 194. North America Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. North America Influenza Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 196. Europe Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 197. Europe Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 198. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 199. Europe Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032) & (Tons) Table 200. Europe Influenza Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 201. Europe Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Europe Influenza Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 203. Europe Influenza Drugs and Vaccines Market Share by Country (2021-2026) Table 204. Europe Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Europe Influenza Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 208. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 209. Asia-Pacific Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032) & (Tons) Table 210. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Influenza Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 213. Asia-Pacific Influenza Drugs and Vaccines Market Share by Country (2021-2026) Table 214. Asia-Pacific Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Asia-Pacific Influenza Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 216. Latin America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 217. Latin America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 218. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 219. Latin America Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032) & (Tons) Table 220. Latin America Influenza Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 221. Latin America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Latin America Influenza Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 223. Latin America Influenza Drugs and Vaccines Market Share by Country (2021-2026) Table 224. Latin America Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Latin America Influenza Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 228. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 229. Middle East and Africa Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032) & (Tons) Table 230. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Influenza Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 233. Middle East and Africa Influenza Drugs and Vaccines Market Share by Country (2021-2026) Table 234. Middle East and Africa Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Middle East and Africa Influenza Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Influenza Drugs and Vaccines Distributors List Table 239. Influenza Drugs and Vaccines Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Influenza Drugs and Vaccines Image Figure 2. Global Influenza Drugs and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza Drugs and Vaccines Sales (2021-2032) & (Tons) Figure 5. Influenza Drugs Image Figure 6. Global Influenza Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 7. Influenza Vaccines Image Figure 8. Global Influenza Vaccines Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Influenza Drugs and Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Influenza Drugs and Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Influenza Drugs and Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (Tons) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (Tons) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Influenza Drugs and Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Influenza Drugs and Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Influenza Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Influenza Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Influenza Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Influenza Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Influenza Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Influenza Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Influenza Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Influenza Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Influenza Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Influenza Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Influenza Drugs and Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Influenza Drugs and Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Drugs
  • Influenza Vaccines
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • CSL
  • Alvogen
  • AstraZeneca
  • BioCryst Pharmaceuticals
  • Bristol Myers Squibb
  • Celgene
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hulan Bio
  • Protein Sciences Corporation
  • Seqirus
  • Serum Institute of India
  • Viatris
  • Beike Bio
  • Bayer
  • Pfizer
  • Jiangsu GDK
  • Sinovac
  • Eli Lilly
  • Roche
  • Novartis
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Influenza Drugs and Vaccines Market by Type
  6. 1.3.1 Influenza Drugs
  7. 1.3.2 Influenza Vaccines
  8. 1.4 Global Influenza Drugs and Vaccines Market Size by Type
  9. 1.4.1 Global Influenza Drugs and Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Influenza Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Influenza Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Influenza Drugs and Vaccines Industry Trends
  2. 2.2 Influenza Drugs and Vaccines Industry Drivers
  3. 2.3 Influenza Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs and Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Influenza Drugs and Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Influenza Drugs and Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Influenza Drugs and Vaccines Price (2021-2026)
  4. 3.4 Global Influenza Drugs and Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza Drugs and Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Influenza Drugs and Vaccines Company, Product Type & Application
  7. 3.7 Global Influenza Drugs and Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza Drugs and Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza Drugs and Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza Drugs and Vaccines Tier 1, Tier 2, and Tier 3
4 Influenza Drugs and Vaccines Regional Status and Outlook
  1. 4.1 Global Influenza Drugs and Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Influenza Drugs and Vaccines Historic Market Size by Region
  3. 4.2.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Influenza Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Influenza Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Influenza Drugs and Vaccines by Application
  1. 5.1 Influenza Drugs and Vaccines Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Influenza Drugs and Vaccines Market Size by Application
  6. 5.2.1 Global Influenza Drugs and Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Influenza Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Influenza Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 Alvogen
  8. 6.2.1 Alvogen Company Information
  9. 6.2.2 Alvogen Business Overview
  10. 6.2.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
  12. 6.2.5 Alvogen Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 BioCryst Pharmaceuticals
  20. 6.4.1 BioCryst Pharmaceuticals Company Information
  21. 6.4.2 BioCryst Pharmaceuticals Business Overview
  22. 6.4.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
  24. 6.4.5 BioCryst Pharmaceuticals Recent Developments
  25. 6.5 Bristol Myers Squibb
  26. 6.5.1 Bristol Myers Squibb Company Information
  27. 6.5.2 Bristol Myers Squibb Business Overview
  28. 6.5.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
  30. 6.5.5 Bristol Myers Squibb Recent Developments
  31. 6.6 Celgene
  32. 6.6.1 Celgene Company Information
  33. 6.6.2 Celgene Business Overview
  34. 6.6.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Celgene Influenza Drugs and Vaccines Product Portfolio
  36. 6.6.5 Celgene Recent Developments
  37. 6.7 Emergent Biosolutions
  38. 6.7.1 Emergent Biosolutions Company Information
  39. 6.7.2 Emergent Biosolutions Business Overview
  40. 6.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
  42. 6.7.5 Emergent Biosolutions Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Hulan Bio
  50. 6.9.1 Hulan Bio Company Information
  51. 6.9.2 Hulan Bio Business Overview
  52. 6.9.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
  54. 6.9.5 Hulan Bio Recent Developments
  55. 6.10 Protein Sciences Corporation
  56. 6.10.1 Protein Sciences Corporation Company Information
  57. 6.10.2 Protein Sciences Corporation Business Overview
  58. 6.10.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
  60. 6.10.5 Protein Sciences Corporation Recent Developments
  61. 6.11 Seqirus
  62. 6.11.1 Seqirus Company Information
  63. 6.11.2 Seqirus Business Overview
  64. 6.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
  66. 6.11.5 Seqirus Recent Developments
  67. 6.12 Serum Institute of India
  68. 6.12.1 Serum Institute of India Company Information
  69. 6.12.2 Serum Institute of India Business Overview
  70. 6.12.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
  72. 6.12.5 Serum Institute of India Recent Developments
  73. 6.13 Viatris
  74. 6.13.1 Viatris Company Information
  75. 6.13.2 Viatris Business Overview
  76. 6.13.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Viatris Influenza Drugs and Vaccines Product Portfolio
  78. 6.13.5 Viatris Recent Developments
  79. 6.14 Beike Bio
  80. 6.14.1 Beike Bio Company Information
  81. 6.14.2 Beike Bio Business Overview
  82. 6.14.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
  84. 6.14.5 Beike Bio Recent Developments
  85. 6.15 Bayer
  86. 6.15.1 Bayer Company Information
  87. 6.15.2 Bayer Business Overview
  88. 6.15.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Bayer Influenza Drugs and Vaccines Product Portfolio
  90. 6.15.5 Bayer Recent Developments
  91. 6.16 Pfizer
  92. 6.16.1 Pfizer Company Information
  93. 6.16.2 Pfizer Business Overview
  94. 6.16.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
  96. 6.16.5 Pfizer Recent Developments
  97. 6.17 Jiangsu GDK
  98. 6.17.1 Jiangsu GDK Company Information
  99. 6.17.2 Jiangsu GDK Business Overview
  100. 6.17.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
  102. 6.17.5 Jiangsu GDK Recent Developments
  103. 6.18 Sinovac
  104. 6.18.1 Sinovac Company Information
  105. 6.18.2 Sinovac Business Overview
  106. 6.18.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
  108. 6.18.5 Sinovac Recent Developments
  109. 6.19 Eli Lilly
  110. 6.19.1 Eli Lilly Company Information
  111. 6.19.2 Eli Lilly Business Overview
  112. 6.19.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
  114. 6.19.5 Eli Lilly Recent Developments
  115. 6.20 Roche
  116. 6.20.1 Roche Company Information
  117. 6.20.2 Roche Business Overview
  118. 6.20.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Roche Influenza Drugs and Vaccines Product Portfolio
  120. 6.20.5 Roche Recent Developments
  121. 6.21 Novartis
  122. 6.21.1 Novartis Company Information
  123. 6.21.2 Novartis Business Overview
  124. 6.21.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Novartis Influenza Drugs and Vaccines Product Portfolio
  126. 6.21.5 Novartis Recent Developments
  127. 6.22 Sanofi
  128. 6.22.1 Sanofi Company Information
  129. 6.22.2 Sanofi Business Overview
  130. 6.22.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
  132. 6.22.5 Sanofi Recent Developments
  133. 6.23 Changchun Institute of Biological
  134. 6.23.1 Changchun Institute of Biological Company Information
  135. 6.23.2 Changchun Institute of Biological Business Overview
  136. 6.23.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
  138. 6.23.5 Changchun Institute of Biological Recent Developments
7 North America by Country
  1. 7.1 North America Influenza Drugs and Vaccines Sales by Country
  2. 7.1.1 North America Influenza Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Influenza Drugs and Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Influenza Drugs and Vaccines Market Size by Country
  6. 7.2.1 North America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Influenza Drugs and Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Influenza Drugs and Vaccines Sales by Country
  2. 8.1.1 Europe Influenza Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Influenza Drugs and Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Influenza Drugs and Vaccines Market Size by Country
  6. 8.2.1 Europe Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Influenza Drugs and Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Influenza Drugs and Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Influenza Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Influenza Drugs and Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Influenza Drugs and Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Influenza Drugs and Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Influenza Drugs and Vaccines Sales by Country
  2. 10.1.1 South America Influenza Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Influenza Drugs and Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Influenza Drugs and Vaccines Market Size by Country
  6. 10.2.1 South America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Influenza Drugs and Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Influenza Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Influenza Drugs and Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Influenza Drugs and Vaccines Value Chain Analysis
  2. 12.1.1 Influenza Drugs and Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Influenza Drugs and Vaccines Production Mode & Process
  7. 12.2 Influenza Drugs and Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Influenza Drugs and Vaccines Distributors
  10. 12.2.3 Influenza Drugs and Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst